Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigmStephen Hanessian, Jianchio Wang, Debra Montgomery, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replicationWarren M Kati, Debra Montgomery, Robert Carrick, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis of potent pyrrolidine influenza neuraminidase inhibitorsA Chris Krueger, Yibo Xu, Warren M Kati, et al.
Journal of Biomolecular Screening|July 5, 2002
Microarray compound screening (microARCS) to identify inhibitors of HIV integraseCaroline A David, Tim Middleton, Debra Montgomery, et al.
Antiviral Research|September 29, 2004
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazolesTim Middleton, Hock B Lim, Debra Montgomery, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2008
Des-A-ring benzothiadiazines: inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerasePamela L Donner, Qinghua Xie, John K Pratt, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazinesJohn K Pratt, Pamela Donner, Keith F McDaniel, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitorsTodd D Bosse, Daniel P Larson, Rolf Wagner, et al.
Pageof 2